Bristol-Myers Squibb Co (BMY)
48.30
+0.46
(+0.96%)
USD |
NYSE |
Apr 18, 16:00
48.30
0.00 (0.00%)
After-Hours: 20:00
Bristol-Myers Squibb Free Cash Flow: 12.65B for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.65B |
| September 30, 2023 | 11.69B |
| June 30, 2023 | 10.72B |
| March 31, 2023 | 11.08B |
| December 31, 2022 | 11.95B |
| September 30, 2022 | 12.72B |
| June 30, 2022 | 14.28B |
| March 31, 2022 | 15.14B |
| December 31, 2021 | 15.23B |
| September 30, 2021 | 14.57B |
| June 30, 2021 | 11.69B |
| March 31, 2021 | 13.20B |
| December 31, 2020 | 13.30B |
| September 30, 2020 | 12.16B |
| June 30, 2020 | 12.41B |
| March 31, 2020 | 9.939B |
| December 31, 2019 | 7.374B |
| September 30, 2019 | 8.709B |
| June 30, 2019 | 7.398B |
| March 31, 2019 | 6.365B |
| December 31, 2018 | 6.115B |
| September 30, 2018 | 3.713B |
| June 30, 2018 | 4.109B |
| March 31, 2018 | 4.586B |
| December 31, 2017 | 4.22B |
| Date | Value |
|---|---|
| September 30, 2017 | 4.429B |
| June 30, 2017 | 4.041B |
| March 31, 2017 | 2.883B |
| December 31, 2016 | 1.843B |
| September 30, 2016 | 1.37B |
| June 30, 2016 | 597.00M |
| March 31, 2016 | 325.00M |
| December 31, 2015 | 1.285B |
| September 30, 2015 | 1.067B |
| June 30, 2015 | 1.573B |
| March 31, 2015 | 2.613B |
| December 31, 2014 | 2.622B |
| September 30, 2014 | 3.451B |
| June 30, 2014 | 3.584B |
| March 31, 2014 | 4.05B |
| December 31, 2013 | 3.008B |
| September 30, 2013 | 2.459B |
| June 30, 2013 | 5.977B |
| March 31, 2013 | 5.586B |
| December 31, 2012 | 6.393B |
| September 30, 2012 | 7.166B |
| June 30, 2012 | 4.333B |
| March 31, 2012 | 4.331B |
| December 31, 2011 | 4.473B |
| September 30, 2011 | 4.509B |
Free Cash Flow Range, Past 5 Years
7.374B
Minimum
Dec 2019
15.23B
Maximum
Dec 2021
11.91B
Average
12.16B
Median
Sep 2020
Free Cash Flow Benchmarks
| Amgen Inc | 7.359B |
| Gilead Sciences Inc | 7.421B |
| Johnson & Johnson | 17.78B |
| Karuna Therapeutics Inc (DELISTED) | -388.74M |
| 2seventy bio Inc | -180.72M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 4.252B |
| Cash from Investing (Quarterly) | -1.346B |
| Cash from Financing (Quarterly) | 967.00M |
| Free Cash Flow Per Share (Quarterly) | 1.929 |
| Free Cash Flow to Equity (Quarterly) | 1.754B |
| Free Cash Flow to Firm (Quarterly) | 4.255B |
| Free Cash Flow Yield | 12.60% |